Literature DB >> 3746333

Recurrent neuroleptic malignant syndrome and hyponatraemia.

W R Gibb, J A Wedzicha, B I Hoffbrand.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3746333      PMCID： PMC1028964          DOI： 10.1136/jnnp.49.8.960

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  3 in total

1.  Drug-induced stated of impaired water excretion.

Authors:  M Miller; A M Moses
Journal:  Kidney Int       Date:  1976-07       Impact factor: 10.612

Review 2.  Current concepts. Neuroleptic malignant syndrome.

Authors:  B H Guzé; L R Baxter
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

3.  Hyponatremia in patients with schizophrenia.

Authors:  I C Gleadhill; T A Smith; J J Yium
Journal:  South Med J       Date:  1982-04       Impact factor: 0.954
  3 in total
  4 in total

1.  Muscle pathology in the neuroleptic malignant syndrome.

Authors:  D T Martin; M Swash
Journal:  J Neurol       Date:  1987-12       Impact factor: 4.849

2.  Recurrence, hyponatraemia and neuroleptic malignant syndrome.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-04       Impact factor: 10.154

Review 3.  Clinical management of neuroleptic malignant syndrome.

Authors:  V L Susman
Journal:  Psychiatr Q       Date:  2001

Review 4.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.